1. Buprenorphine treatment of opioid dependence: a review;Bickel;Exp. Clin. Psychopharmacol.,1995
2. Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans;Bickel;J. Pharmacol. Exp. Ther.,1988
3. Bigelow, G.E., Brooner, R.K., Walsh, S.L., Preston, K.L., Liebson, I.A., 1995. Community outcomes following exposure to cocaine or opioids. In: Harris, L.S. (Ed.), Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting. US Government Printing Office, Washinton, DC, USA. NIDA Research Monograph 153, p. 354.
4. Agonist and antagonist properties of buprenorphine: a new antinociceptive agent;Cowan;Br. J. Pharmacol.,1977
5. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1996. Structured Clinical Interview for DSM-IV Axis Disorders—Patient Edition Biometrics Research Department, NY State Psychiatric Institute (SCID-I/P, Version 2.0).